A Rare Case of Polycythemia Vera Following Acute Undifferentiated Leukemia Remission
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) characterized by the abnormal proliferation of red blood cells, and it is associated with leukocytosis and thrombocytosis [1]. A Janus kinase 2 ( JAK2 ) V617F mutation is found in 95% of PV patients and influences its pathogenesis and diagnosis [1-4]. Generally, AML development is a late event in PV patients [1, 5], and leukemic transformation occurs in 5-15% of patients [4]. We report a case of PV after complete remission (CR) of acute undifferentiated leukemia.
Abstract
Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) characterized by the abnormal proliferation of red blood cells, and it is associated with leukocytosis and thrombocytosis [1]. A Janus kinase 2 ( JAK2 ) V617F mutation is found in 95% of PV patients and influences its pathogenesis and diagnosis [1-4]. Generally, AML development is a late event in PV patients [1, 5], and leukemic transformation occurs in 5-15% of patients [4]. We report a case of PV after complete remission (CR) of acute undifferentiated leukemia.
참고문헌 (10)
- Passamonti F, "A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications", Leukemia, 24, pp.1574~1579 (2010)
- Antonioli E, "Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance", Blood, 110, pp.4620~4621 (2007)
- Tefferi A, "Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management", Am J Hematol, 88, pp.507~516 (2013)
- Lee HJ, "The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia", Clin Cancer Res, 19, pp.327~335 (2013)
- Gangat N, "Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation", Br J Haematol, 138, pp.354~358 (2007)
- Dong Wook Jekarl, "JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome", myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia, 2010, pp.45(1), 46~50[DOI]
- Swaminathan S, "Novel immunophenotypic and morphologic presentation in acute myeloid leukemia (AML) with JAK2 V617F mutation", Eur J Haematol, 84, pp.180~182 (2010)
- Belotti A, "Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report", Acta Haematol, 126, pp.52~53 (2011)
- Portell CA, "De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone", Br J Haematol, 157, pp.266~267 (2012)
- Chabannon C, "A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission", Leukemia, 8, pp.1243~1244 (1994)
